BioMarin Reaches New 52-Week High (BMRN)
NEW YORK (TheStreet) -- BioMarin Pharmaceuticals (Nasdaq:BMRN) hit a new 52-week high Monday as it is currently trading at $42.38, above its previous 52-week high of $42.37 with two million shares traded as of 1:45 p.m. ET. Average volume has been 1.5 million shares over the past 30 days. BioMarin has a market cap of $4.81 billion and is part of the health care sector and drugs industry. Shares are up 18.6% year to date as of the close of trading on Friday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV